Startups
Ingenix.ai
AI and computational biology company developing a Biological Reasoning Engine for pharmaceutical research and development. Its Modality Fusion architecture integrates models and representations across biological scales, from molecules to patients, and combines clinical data, omics, scientific literature, imaging and biological pathways. The engine produces mechanistic hypotheses, step-by-step reasoning and evidence chains with source provenance to help research teams prioritize experiments, biomarkers, drug designs and clinical positioning. Examples include antibody-drug conjugate design prioritization, translational evidence synthesis and comparison of drug assets. The company offers a Qualified Access Program for partners bringing translational and clinical research questions; its outputs support scientific decision-making and experimental validation.